1 |
The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC |
|
|
| Cheng-Fan Lee, Yu-An Chen, Elizabeth Hernandez, Rey-Chen Pong, Shihong Ma, Mia Hofstad, Payal Kapur, Haiyen Zhau, Leland WK Chung, Chih-Ho Lai, Ho Lin, Ming-Shyue Lee, Ganesh V Raj, Jer-Tsong Hsieh |
|
| Clinical and Translational Medicine. 2022; 12(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Molecular Mechanisms Underlying the Development of Neuroendocrine Prostate Cancer |
|
|
| Shiqin Liu, Busola Ruth Alabi, Qingqing Yin, Tanya Stoyanova |
|
| Seminars in Cancer Biology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation |
|
|
| Lina Merkens, Verena Sailer, Davor Lessel, Ella Janzen, Sarah Greimeier, Jutta Kirfel, Sven Perner, Klaus Pantel, Stefan Werner, Gunhild von Amsberg |
|
| Journal of Experimental & Clinical Cancer Research. 2022; 41(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective |
|
|
| Jian Huang, Biyun Lin, Benyi Li |
|
| Frontiers in Oncology. 2022; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers |
|
|
| Aaron R. Waddell,Haojie Huang,Daiqing Liao |
|
| Cancers. 2021; 13(12): 2872 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation |
|
|
| Shian-Ren Lin,Hsiu-Lien Yeh,Yen-Nien Liu |
|
| Cancers. 2021; 13(14): 3452 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Imaging of Neuroendocrine Prostatic Carcinoma |
|
|
| Ahmed Taher, Corey T. Jensen, Sireesha Yedururi, Devaki Shilpa Surasi, Silvana C. Faria, Tharakeshwar K. Bathala, Bilal Mujtaba, Priya Bhosale, Nicolaus Wagner-Bartak, Ajaykumar C. Morani |
|
| Cancers. 2021; 13(22): 5765 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer |
|
|
| Thanakorn Pungsrinont, Julia Kallenbach, Aria Baniahmad |
|
| International Journal of Molecular Sciences. 2021; 22(20): 11088 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
The Role of the CREB Protein Family Members and the Related Transcription Factors in Radioresistance Mechanisms |
|
|
| Gianmarco Stati, Francesca Passaretta, Florelle Gindraux, Lucia Centurione, Roberta Di Pietro |
|
| Life. 2021; 11(12): 1437 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Caryophyllene Oxide, the Active Compound Isolated from Leaves of Hymenaea courbaril L. (Fabaceae) with Antiproliferative and Apoptotic Effects on PC-3 Androgen-Independent Prostate Cancer Cell Line |
|
|
| Claudia Delgado,Gina Mendez-Callejas,Crispin Celis |
|
| Molecules. 2021; 26(20): 6142 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs |
|
|
| Eva Slabáková, Zuzana Kahounová, Jirina Procházková, Karel Soucek |
|
| Non-Coding RNA. 2021; 7(4): 75 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Epigenetic mechanisms underlying prostate cancer radioresistance |
|
|
| Catarina Macedo-Silva,Rosaria Benedetti,Fortunato Ciardiello,Salvatore Cappabianca,Carmen Jerónimo,Lucia Altucci |
|
| Clinical Epigenetics. 2021; 13(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms |
|
|
| William Butler,Jiaoti Huang |
|
| Precision Clinical Medicine. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13 |
|
|
| Kosuke Okasho,Kei Mizuno,Tomohiro Fukui,Yen-Yi Lin,Yuki Kamiyama,Takuro Sunada,Xin Li,Hiroko Kimura,Takayuki Sumiyoshi,Takayuki Goto,Takashi Kobayashi,Dong Lin,Yuzhuo Wang,Colin C. Collins,Takahiro Inoue,Osamu Ogawa,Shusuke Akamatsu |
|
| Cancer Science. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Molecular events in neuroendocrine prostate cancer development |
|
|
| Yong Wang,Yu Wang,Xinpei Ci,Stephen Y. C. Choi,Francesco Crea,Dong Lin,Yuzhuo Wang |
|
| Nature Reviews Urology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction |
|
|
| Liyuan Yin,Peizhen Hu,Xianping Shi,Weiping Qian,Haiyen E. Zhau,Stephen J. Pandol,Michael S. Lewis,Leland W. K. Chung,Ruoxiang Wang |
|
| Scientific Reports. 2020; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC) |
|
|
| Bhavana Jonnalagadda,Sumathy Arockiasamy,Sriram Krishnamoorthy |
|
| Life Sciences. 2020; : 118208 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
18 |
Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells |
|
|
| Belén G. Sánchez,Alicia Bort,Diana Vara-Ciruelos,Inés Díaz-Laviada |
|
| Cells. 2020; 9(6): 1441 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
19 |
Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review |
|
|
| Jing Hu,Bo Han,Jiaoti Huang |
|
| Archives of Pathology & Laboratory Medicine. 2020; 144(3): 320 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
20 |
Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression |
|
|
| Ninghan Feng,Jiaoti Huang |
|
| Asian Journal of Andrology. 2019; 0(0): 0 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
21 |
Incidental finding of a small cell neuroendocrine carcinoma of the ureter |
|
|
| Obinna Obi-Njoku,Chris Bell,Prashant Ravindran Menon,Iqbal Shergill |
|
| BMJ Case Reports. 2019; 12(7): e229290 |
|
| [Pubmed] [Google Scholar] [DOI] |
|